Europe to Register Robust Growth in the Non-Invasive Prenatal Testing Market by 2024

(Newswire.net — July 27, 2017) New York City, New York — Growing need for testing health of babies has led to an upsurge in demand for noninvasive parental tests. Increasing prevalence of ADHD diseases will further impact growth of the global noninvasive parental market positively.  

Factors Propelling Growth of the Global Market

Increasing introduction of generic medications among youngsters is likely to impact growth of the global noninvasive parental testing market during the predicted period. Moreover, increasing presence of ADHD disorders among youngsters has revved up demand for noninvasive parental testing treatment in the various healthcare institutions. Additionally, growing need to test the health of soon-to-be-born baby is likely to escalate demand for non-invasive parental testing services throughout 2024. Such factors will contribute towards growth of the global noninvasive parental testing market during the predicted period.

A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/11218 

Further, manufacturers are increasingly integrating innovation in various medical devices. Availability of enhanced medical devices is likely to witness a significant demand across various healthcare institutes. Such factors will contribute towards growth of the global noninvasive parental testing market significantly during the predicted period. On the other hand, increasing instances of drug abuse are likely to impact growth of the global market of noninvasive parental market during the predicted period.

Hospitals to Represent a Leading Segment

Panel 1 noninvasive parental testing among other testing services is likely to represent significant revenue share in the global noninvasive parental testing market by the end of 2024. This segment is likely to represent more than US$ 850 million in terms of revenue by 2024 end. Panel 2 among other noninvasive tests will reflect a robust CAGR growth of 9.7% in the global market of noninvasive parental testing market throughout 2024. Hospitals among other end users are likely to represent a major segment by the end of 2024. Panel 3 segment among other tests is likely to witness 1.9X growth in the global market of noninvasive parental testing market by 2024 end. Moreover, this segment will account for half of the market value globally during the predicted period. Hospitals will register the highest growth of 11.1% CAGR throughout 2024.

Europe to Register a Robust Market Growth

North America among other regions will represent nearly 60% revenue share in the global market of noninvasive parental testing market by the end of 2024. The noninvasive market in APAC will create an incremental opportunity of US$ 18 million in 2017 over 2016. In addition, the noninvasive parental testing market in Europe will witness robust growth in the global market. This segment will reflect a CAGR growth of 10% in the global noninvasive parental testing market throughout 2024.

Request to view table of content @ http://www.persistencemarketresearch.com/market-research/non-invasive-prenatal-testing-nipt-market/toc 

Market Players Operating in the Global Market

Key market players operating in the global noninvasive parental testing market include BGI Diagnosis Co. Ltd., Ariosa Diagnostics, Inc., Illumina, Inc., Berry Genomics Corporation, Natera, Inc., LifeCodexx AG, Quest Diagnostic Incorporated, Laboratory Corporation of America Holdings, and Sequenom, Inc. Majority of the global market players operating in the global market of noninvasive parental testing market are based in the U.S.